fda compounding semaglutide enforcement october 2025 news 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded "semaglutide" is not FDA-approved

As it is major surgery, therefore, it must be performed by a board certified plastic surgeon in a well-equipped and recognized surgical center

If this article provided you with helpful information or reassurance, please consider supporting my work through Ko-fi

Quick and affordable Super fast delivery and the price was way better than my last order

All three major weekly GLP-class agents sit in a similar half-life band, which is why all three use the same weekly injection schedule: No head-to-head pharmacokinetic trial has directly compared these three compounds

And this puts the decision about whether to use GLP-1 medications in context